Icon Advisers Inc Supernus Pharmaceuticals, Inc. Transaction History

Icon Advisers Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 01, 2020	SELL	$14.45 - $24.69 $762,584 - $1.3 Million	-52,774 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$25.47 - $33.37 $618,921 - $810,890	-24,300 Reduced 31.53%	52,774 $1.45 Million
Q2 2019 Aug 02, 2019	SELL	$29.96 - $38.87 $185,752 - $240,993	-6,200 Reduced 7.45%	77,074 $2.55 Million
Q4 2018 Feb 04, 2019	BUY	$30.84 - $49.51 $193,490 - $310,625	6,274 Added 8.15%	83,274 $2.77 Million
Q3 2018 Nov 05, 2018	BUY	$42.7 - $56.55 $3.29 Million - $4.35 Million	77,000 New	77,000 $3.88 Million

281

60.6M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.9B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Icon Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Icon Advisers Inc with notifications on news.